title: Foot and Knee Behaviour During Gait in Response to the Use of Additional Means of Treatment in Cerebral Palsied Children
abstract: Physiological human gait is characterized by tree-dimensional pelvis movements, which make that gait is smooth and does not require excessive energy expenditure. In children with cerebral palsy determinants of the pelvis may be affected, mainly due to pathological afferent synergisms. Therefore many specialists is looking for ways to improve this situation. The aim of this study was to verify whether the use of botulinium toxin or inhibitive casts affects the kinematic parameters of the pelvis during the gait of children with hemiparetic form of cerebral palsy.
  
  
  
  The study involved 34 hemiparetic children with cerebral palsy aged 7-14 years who reached the capacity of walking. All were improving by neurodevelop-mental treatment according to NDT-Bobath method. Two groups were created. In the first group inhibiting casting was used in 16 children. In the second group botulinium toxin was injected in 18 children. Gait analysis was performed before and after using those type of treatment. Ultrasonic CMS-HS system (Zebris) was used for three dimensional gait analysis.
  
  
  
  Despite of the characteristic for hemiplegic gait pattern asymmetry, various ab-normalities of pelvis kinematic parameters were observed. Gait symmetry was improved aafter the treatment. Using inhibiting casts also improved kinematic parameters of the pelvis, especially in those children who are found deficit of decreasing and rotation of the pelvis.
  
  
  
  1) The use of Btx-A or inhibitive casts results in improving temporal- spatial parameters of gait of cerebral palsied children with hemiparesis. 2) The improvement of kinematic pelvis parameters are obtained through the use of inhibitive casts, while the use of Btx-A does not have a significant impact on them.
authors.affiliation: Division of Physiotherapy, Higher School of Administration Bielsko-Biala, Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Czupryna
authors.forename: Janusz
authors.initials: J
authors.lastname: Nowotny
mesh_terms: D000293:Adolescent; D001696:Biomechanical Phenomena; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000150:complications / Q000503:physiopathology* / Q000534:rehabilitation*; D002648:Child; D005684:Gait / Q000187:drug effects*; D006801:Humans; D008297:Male; D010291:Paresis / Q000150:complications / Q000503:physiopathology* / Q000534:rehabilitation*; D010388:Pelvis / Q000503:physiopathology*; D016138:Walking
chemical_list: D019274:Botulinum Toxins, Type A